Journal of Clinical Epidemiology
Volume 59, Issue 5 , Pages 437.e1-437.e24 , May 2006

A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods

  • Til Stürmer

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    • Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
    • Corresponding Author InformationCorresponding author. Tel.: 617-278-0627; fax: 617-232-8602.
    • ,
  • Manisha Joshi

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    • ,
  • Robert J. Glynn

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    • Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
    • ,
  • Jerry Avorn

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    • ,
  • Kenneth J. Rothman

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    • Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA
    • ,
  • Sebastian Schneeweiss

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA

,Accepted 15 June 2005.

References 

  1. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887–1892
  2. Writing group for the Women's Health Initiative investigators . Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–333
  3. Walker AM. Confounding by indication. Epidemiology. 1996;7:335–336
  4. Miettinen OS. Stratification by a multivariate confounder score. Am J Epidemiol. 1976;104:609–620
  5. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41–55
  6. Rosenbaum PR, Rubin DB. The bias due to incomplete matching. Biometrics. 1985;41:103–116
  7. Gu XS, Rosenbaum PR. Comparison of multivariate matching methods: structures, distances, and algorithms. J Comput Graph Stat. 1993;2:405–420
  8. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. In: Proceedings of the 26th Annual SAS Users Group International Conference. April 22–25, 2001. Long Beach California. Cary, NC: SAS Institute; 2001:214–26 [Available at: http://www2.sas.com/proceedings/sugi26/p214-26.pdf. Accessed January 2005].
  9. Rubin DB, Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics. 1996;52:249–264
  10. Cochran WG. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics. 1968;24:205–213
  11. Brenner H, Blettner M. Controlling for continuous confounders in epidemiologic research. Epidemiology. 1997;8:429–434
  12. Rubin DB, Thomas N. Combining propensity score matching with additional adjustment for prognostic covariates. J Am Stat Assoc. 2000;95:573–585
  13. D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–2281
  14. Brookhart MA, van der Laan MJ. A semiparametric model selection criterion with applications to the marginal structural model. Comput Stat Data Anal 2006;50:475–98.
  15. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol. 1999;150:327–333
  16. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using sub-classification on the propensity score. J Am Stat Assoc. 1984;79:516–524
  17. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757–763
  18. Abbott KC, Trespalacios FC, Agodoa LY. Arteriovenous fistula use and heart disease in long-term elderly hemodialysis patients: analysis of United States Renal Data System Dialysis Morbidity and Mortality Wave II. J Nephrol. 2003;16:822–830
  19. Abramov D, Tamariz M, Fremes S, et al. Impact of preoperative renal dysfunction on cardiac surgery results. Asian Cardiovasc Thorac Ann. 2003;11:42–47
  20. Abramov D, Tamariz M, Serrick CI, et al. The influence of cardiopulmonary bypass flow characteristics on the clinical outcome of 1820 coronary bypass patients. Can J Cardiol. 2003;19:237–243
  21. Allen-Ramey FC, Duong PT, Goodman DC, et al. Treatment effectiveness of inhaled corticosteroids and leukotriene modifiers for patients with asthma: an analysis from managed care data. Allergy Asthma Proc. 2003;24:43–51
  22. Aronow HD, Novaro GM, Lauer MS, et al. In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis. Arch Intern Med. 2003;163:2576–2582
  23. Ascione R, Narayan P, Rogers CA, Lim KH, Capoun R, Angelini GD. Early and midterm clinical outcome in patients with severe left ventricular dysfunction undergoing coronary artery surgery. Ann Thorac Surg. 2003;76:793–799
  24. Banbury MK, White JA, Blackstone EH, Cosgrove DM. Vacuum-assisted venous return reduces blood usage. J Thorac Cardiovasc Surg. 2003;126:680–687
  25. Beddhu S, Samore MH, Roberts MS, et al. Impact of timing of initiation of dialysis on mortality. J Am Soc Nephrol. 2003;14:2305–2312
  26. Bhatt DL, Chew DP, Lincoff AM, et al. Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes. Am J Cardiol. 2003;92:136–140
  27. Boening A, Friedrich C, Hedderich J, Schoettler J, Fraund S, Cremer JT. Early and medium-term results after on-pump and off-pump coronary artery surgery: a propensity score analysis. Ann Thorac Surg. 2003;76:2000–2006
  28. Brener SJ, Ellis SG, Schneider J, Apperson-Hansen C, Topol EJ. Abciximab-facilitated percutaneous coronary intervention and long-term survival–a prospective single-center registry. Eur Heart J. 2003;24:630–638
  29. Bukhari MA, Wiles NJ, Lunt M, et al. Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study. Arthritis Rheum. 2003;48:46–53
  30. Calafiore AM, Di Mauro M, Canosa C, et al. Myocardial revascularization with and without cardiopulmonary bypass in multivessel disease: impact of strategy on midterm outcome. Ann Thorac Surg. 2003;76:32–36
  31. Calafiore AM, Di Mauro M, Canosa C, Di Giammarco G, Iaco AL, Contini M. Early and late outcome of myocardial revascularization with and without cardiopulmonary bypass in high risk patients (EuroSCORE > or = 6). Eur J Cardiothorac Surg. 2003;23:360–367
  32. Chan AW, Bhatt DL, Chew DP, et al. Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation. 2003;107:1750–1756
  33. Chan AW, Moliterno DJ, Berger PB, et al. Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET). J Am Coll Cardiol. 2003;42:1188–1195
  34. Cho L, Bhatt DL, Marso SP, et al. An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial. Am J Med. 2003;114:106–111
  35. Christakis NA, Iwashyna TJ. The health impact of health care on families: a matched cohort study of hospice use by decedents and mortality outcomes in surviving, widowed spouses. Soc Sci Med. 2003;57:465–475
  36. Dendukuri N, Normand SL, McNeil BJ. Impact of cardiac service availability on case-selection for angiography and survival associated with angiography. Health Serv Res. 2003;38:21–40
  37. Ezri T, Weisenberg M, Khazin V, et al. Difficult laryngoscopy: incidence and predictors in patients undergoing coronary artery bypass surgery versus general surgery patients. J Cardiothorac Vasc Anesth. 2003;17:321–324
  38. Flameng WJ, Herijgers P, Dewilde S, Lesaffre E. Continuous retrograde blood cardioplegia is associated with lower hospital mortality after heart valve surgery. J Thorac Cardiovasc Surg. 2003;125:121–125
  39. Frolkis JP, Pothier CE, Blackstone EH, Lauer MS. Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med. 2003;348:781–790
  40. Gillinov AM, Faber C, Houghtaling PL, et al. Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease. J Thorac Cardiovasc Surg. 2003;125:1350–1362
  41. Girou E, Brun-Buisson C, Taille S, Lemaire F, Brochard L. Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema. JAMA. 2003;290:2985–2991
  42. Grzybowski M, Clements EA, Parsons L, et al. Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: a propensity analysis. JAMA. 2003;290:1891–1898
  43. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900–2907
  44. Hall JA, Summers KH, Obenchain RL. Cost and utilization comparisons among propensity score-matched insulin lispro and regular insulin users. J Manag Care Pharm. 2003;9:263–268
  45. Hamamoto M, Bando K, Kobayashi J, et al. Durability and outcome of aortic valve replacement with mitral valve repair versus double valve replacement. Ann Thorac Surg. 2003;75:28–33
  46. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115:529–535
  47. Heuschmann PU, Berger K, Misselwitz B, et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke. 2003;34:1106–1113
  48. Hughes MG, Evans HL, Lightfoot L, et al. Does prior transfusion worsen outcomes from infection in surgical patients?. Surg Infect (Larchmt). 2003;4:335–343
  49. Ishani A, Ibrahim HN, Gilbertson D, Collins AJ. The impact of residual renal function on graft and patient survival rates in recipients of preemptive renal transplants. Am J Kidney Dis. 2003;42:1275–1282
  50. Karthik S, Musleh G, Grayson AD, et al. Effect of avoiding cardiopulmonary bypass in non-elective coronary artery bypass surgery: a propensity score analysis. Eur J Cardiothorac Surg. 2003;24:66–71
  51. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology. 2003;60:620–625
  52. Koch CG, Khandwala F, Nussmeier N, Blackstone EH. Gender and outcomes after coronary artery bypass grafting: a propensity-matched comparison. J Thorac Cardiovasc Surg. 2003;126:2032–2043
  53. Krzyzanowska MK, Weeks JC, Earle CC. Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness. J Clin Oncol. 2003;21:3409–3414
  54. Kurlansky PA, Williams DB, Traad EA, et al. Arterial grafting results in reduced operative mortality and enhanced long-term quality of life in octogenarians. Ann Thorac Surg. 2003;76:418–426
  55. Landesberg G, Mosseri M, Wolf YG, et al. Preoperative thallium scanning, selective coronary revascularization, and long-term survival after major vascular surgery. Circulation. 2003;108:177–183
  56. Leon AC, Solomon DA, Mueller TI, et al. A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness. Am J Psychiatry. 2003;160:727–733
  57. Macaubas C, de Klerk NH, Holt BJ, et al. Association between antenatal cytokine production and the development of atopy and asthma at age 6 years. Lancet. 2003;362:1192–1197
  58. Magee MJ, Coombs LP, Peterson ED, Mack MJ. Patient selection and current practice strategy for off-pump coronary artery bypass surgery. Circulation. 2003;108S1:II9–14
  59. Martin S, Kolb H, Beuth J, van Leendert R, Schneider B, Scherbaum WA. Change in patients' body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrospective cohort study. Diabetologia. 2003;46:1611–1617
  60. Moss RR, Humphries KH, Gao M, et al. Outcome of mitral valve repair or replacement: a comparison by propensity score analysis. Circulation. 2003;108S1:II90–II97
  61. Murthy SC, Law S, Whooley BP, Alexandrou A, Chu KM, Wong J. Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg. 2003;126:1162–1167
  62. Peterson ED, Pollack CV, Roe MT, et al. Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4. J Am Coll Cardiol. 2003;42:45–53
  63. Rice TW, Adelstein DJ, Chidel MA, et al. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg. 2003;126:1590–1596
  64. Rubins HB, Nelson DB, Noorbaloochi S, Nugent S. Effectiveness of lipid-lowering medications in outpatients with coronary heart disease in the Department of Veterans Affairs System. Am J Cardiol. 2003;92:1177–1182
  65. Schmitz C, Weinreich S, White J, et al. Can particulate extraction from the ascending aorta reduce neurologic injury in cardiac surgery?. J Thorac Cardiovasc Surg. 2003;126:1829–1838
  66. Schumacher K, Schneider B, Reich G, et al. Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients: a controlled epidemiological multicentric retrolective cohort study. Anticancer Res. 2003;23:5081–5087
  67. Schwarz RE, Smith DD, Keny H, et al. Impact of intraoperative radiation on postoperative and disease-specific outcome after pancreatoduodenectomy for adenocarcinoma: a propensity score analysis. Am J Clin Oncol. 2003;26:16–21
  68. Seeger JD, Walker AM, Williams PL, Saperia GM, Sacks FM. A propensity score-matched cohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocardial infarction. Am J Cardiol. 2003;92:1447–1451
  69. Srinivasan AK, Grayson AD, Pullan DM, Fabri BM, Dihmis WC. Effect of preoperative aspirin use in off-pump coronary artery bypass operations. Ann Thorac Surg. 2003;76:41–45
  70. Stamou SC, Kapetanakis EI, Lowery R, Jablonski KA, Frankel TL, Corso PJ. Allogeneic blood transfusion requirements after minimally invasive versus conventional aortic valve replacement: a risk-adjusted analysis. Ann Thorac Surg. 2003;76:1101–1106
  71. Trichon BH, Glower DD, Shaw LK, et al. Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation. Circulation. 2003;108S1:II103–II110
  72. Vakili BA, Kaplan RC, Slater JN, et al. A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention. Am J Cardiol. 2003;91:946–950
  73. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA. 2003;290:3207–3214
  74. Winkelmayer WC, Owen WF, Levin R, Avorn J. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol. 2003;14:486–492
  75. Young-Xu Y, Chan KA, Liao JK, Ravid S, Blatt CM. Long-term statin use and psychological well-being. J Am Coll Cardiol. 2003;42:690–697
  76. Ayanian JZ, Landrum MB, Guadagnoli E, Gaccione P. Specialty of ambulatory care physicians and mortality among elderly patients after myocardial infarction. N Engl J Med. 2002;347:1678–1686
  77. Carmeli Y, Eliopoulos G, Mozaffari E, Samore M. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med. 2002;162:2223–2228
  78. Chan AW, Bhatt DL, Chew DP, et al. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation. 2002;105:691–696
  79. Chan AW, Quinn MJ, Bhatt DL, et al. Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention. J Am Coll Cardiol. 2002;40:669–675
  80. Cole JA, Loughlin JE, Ajene AN, Rosenberg DM, Cook SE, Walker AM. The effect of zanamivir treatment on influenza complications: a retrospective cohort study. Clin Ther. 2002;24:1824–1839
  81. Elad Y, French WJ, Shavelle DM, Parsons LS, Sada MJ, Every NR. Primary angioplasty and selection bias inpatients presenting late (>12 h) after onset of chest pain and ST elevation myocardial infarction. J Am Coll Cardiol. 2002;39:826–833
  82. Ferguson TB, Coombs LP, Peterson ED. Internal thoracic artery grafting in the elderly patient undergoing coronary artery bypass grafting: room for process improvement?. J Thorac Cardiovasc Surg. 2002;123:869–880
  83. Ferguson TB, Coombs LP, Peterson ED. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA. 2002;287:2221–2227
  84. Grunkemeier GL, Payne N, Jin R, Handy JR. Propensity score analysis of stroke after off-pump coronary artery bypass grafting. Ann Thorac Surg. 2002;74:301–305
  85. Iwashyna TJ, Lamont EB. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol. 2002;20:3992–3998
  86. Jenkins NP, Keevil BG, Hutchinson IV, Brooks NH. Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease. Am J Med. 2002;112:269–274
  87. Kilborn MJ, Rathore SS, Gersh BJ, Oetgen WJ, Solomon AJ. Amiodarone and mortality among elderly patients with acute myocardial infarction with atrial fibrillation. Am Heart J. 2002;144:1095–1101
  88. Luedtke R, Weber U, Fischer I, Friese KH, Moeller H. An example on the value of non-randomisation in clinical trials in complementary medicine. Forsch Komplementarmed Klass Naturheilkd. 2002;9:105–109
  89. Magee MJ, Jablonski KA, Stamou SC, et al. Elimination of cardiopulmonary bypass improves early survival for multivessel coronary artery bypass patients. Ann Thorac Surg. 2002;73:1196–1202
  90. Majahalme S, Kim MH, Bruckman D, Tarkka M, Eagle KA. Atrial fibrillation after coronary surgery: comparison between different health care systems. Int J Cardiol. 2002;82:209–218
  91. Mehta RL, McDonald B, Gabbai F, et al. Nephrology consultation in acute renal failure: does timing matter?. Am J Med. 2002;113:456–461
  92. Mehta RL, Pascual MT, Soroko S, Chertow GM. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288:2547–2553
  93. Mukherjee D, Mahaffey KW, Moliterno DJ, et al. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B). Am Heart J. 2002;144:995–1002
  94. Neugut AI, Fleischauer AT, Sundararajan V, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol. 2002;20:2643–2650
  95. Newby LK, Kristinsson A, Bhapkar MV, et al. Early statin initiation and outcomes in patients with acute coronary syndromes. JAMA. 2002;287:3087–3095
  96. Patel U, Spitznagel E, Piccirillo J. Multivariate analyses to assess treatment effectiveness in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2002;128:497–503
  97. Pereira JJ, Lauer MS, Bashir M, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol. 2002;39:1356–1363
  98. Rahme E, Pettitt D, LeLorier J. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population. Arthritis Rheum. 2002;46:3046–3054
  99. Sabik JF, Gillinov AM, Blackstone EH, et al. Does off-pump coronary surgery reduce morbidity and mortality?. J Thorac Cardiovasc Surg. 2002;124:698–707
  100. Shavelle DM, Parsons L, Sada MJ, French WJ, Every NR. Is there a benefit to early angiography in patients with ST-segment depression myocardial infarction? An observational study. Am Heart J. 2002;143:488–496
  101. Shireman TI, Braman KS. Impact and cost-effectiveness of respiratory syncytial virus prophylaxis for Kansas Medicaid's high-risk children. Arch Pediatr Adolesc Med. 2002;156:1251–1255
  102. Shishehbor MH, Baker DW, Blackstone EH, Lauer MS. Association of educational status with heart rate recovery: a population-based propensity analysis. Am J Med. 2002;113:643–649
  103. Sin DD, McAlister FA. The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure. Am J Med. 2002;113:650–656
  104. Stamou SC, Jablonski KA, Pfister AJ, et al. Stroke after conventional versus minimally invasive coronary artery bypass. Ann Thorac Surg. 2002;74:394–399
  105. Stenestrand U, Wallentin L. Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study. Lancet. 2002;359:1805–1811
  106. Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF, Neugut AI. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med. 2002;136:349–357
  107. Teufelsbauer H, Prusa AM, Wolff K, et al. Endovascular stent grafting versus open surgical operation in patients with infrarenal aortic aneurysms: a propensity score-adjusted analysis. Circulation. 2002;106:782–787
  108. Umana JP, Lai DT, Mitchell RS, et al. Is medical therapy still the optimal treatment strategy for patients with acute type B aortic dissections?. J Thorac Cardiovasc Surg. 2002;124:896–910
  109. Umana JP, Miller DC, Mitchell RS. What is the best treatment for patients with acute type B aortic dissections–medical, surgical, or endovascular stent-grafting?. Ann Thorac Surg. 2002;74:S1840–S1843
  110. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288:1499–1507
  111. Weber U, Luedtke R, Friese KH, Fischer I, Moeller H. A non-randomised pilot study to compare complementary and conventional treatments of acute sinusitis. Forsch Komplementarmed Klass Naturheilkd. 2002;9:99–104
  112. Weiss JP, Saynina O, McDonald KM, McClellan MB, Hlatky MA. Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among Medicare beneficiaries. Am J Med. 2002;112:519–527
  113. Winkelmayer WC, Glynn RJ, Mittleman MA, Levin R, Pliskin JS, Avorn J. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol. 2002;13:2353–2362
  114. Aronow HD, Topol EJ, Roe MT, et al. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet. 2001;357:1063–1068
  115. Beuth J, Ost B, Pakdaman A, et al. Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients: results of an epidemiological multicentre retrolective cohort study. Cancer Chemother Pharmacol. 2001;47S:S45–S54
  116. Carmeli Y, Castro J, Eliopoulos GM, Samore MH. Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam. Antimicrob Agents Chemother. 2001;45:275–279
  117. Dammann O, Allred EN, Kuban KC, et al. Hypocarbia during the first 24 postnatal hours and white matter echolucencies in newborns < or = 28 weeks gestation. Pediatr Res. 2001;49:388–393
  118. Earle CC, Tsai JS, Gelber RD, Weinstein MC, Neumann PJ, Weeks JC. Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol. 2001;19:1064–1070
  119. Ellis SG, Brener SJ, Lincoff AM, et al. beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise. Circulation. 2001;104:2685–2688
  120. Feng D, D'Agostino RB, Silbershatz H, et al. Hemostatic state and atrial fibrillation (the Framingham Offspring Study). Am J Cardiol. 2001;87:168–171
  121. Foody JM, Cole CR, Blackstone EH, Lauer MS. A propensity analysis of cigarette smoking and mortality with consideration of the effects of alcohol. Am J Cardiol. 2001;87:706–711
  122. Gillinov AM, Wierup PN, Blackstone EH, et al. Is repair preferable to replacement for ischemic mitral regurgitation?. J Thorac Cardiovasc Surg. 2001;122:1125–1141
  123. Gum PA, Thamilarasan M, Watanabe J, Blackstone EH, Lauer MS. Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: A propensity analysis. JAMA. 2001;286:1187–1194
  124. Hayashi K, Hasegawa K, Kobayashi S. Effects of angiotensin-converting enzyme inhibitors on the treatment of anemia with erythropoietin. Kidney Int. 2001;60:1910–1916
  125. Ioannidis JP, Galanos O, Katritsis D, et al. Early mortality and morbidity of bilateral versus single internal thoracic artery revascularization: propensity and risk modeling. J Am Coll Cardiol. 2001;37:521–528
  126. Keating NL, Weeks JC, Landrum MB, Borbas C, Guadagnoli E. Discussion of treatment options for early-stage breast cancer: effect of provider specialty on type of surgery and satisfaction. Med Care. 2001;39:681–691
  127. Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care. 2001;24:483–488
  128. Mast ST, Gersing KR, Anstrom KJ, Krishnan KR, Califf RM, Jollis JG. Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation. Am J Cardiol. 2001;87:989–993
  129. Mitra N, Schnabel FR, Neugut AI, Heitjan DF. Estimating the effect of an intensive surveillance program on stage of breast carcinoma at diagnosis: a propensity score analysis. Cancer. 2001;91:1709–1715
  130. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Prior alcohol consumption and mortality following acute myocardial infarction. JAMA. 2001;285:1965–1970
  131. Normand ST, Landrum MB, Guadagnoli E, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54:387–398
  132. Osswald BR, Blackstone EH, Tochtermann U, et al. Does the completeness of revascularization affect early survival after coronary artery bypass grafting in elderly patients?. Eur J Cardiothorac Surg. 2001;20:120–125
  133. Peterson JG, Topol EJ, Roe MT, et al. PURSUIT Investigators; Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. Am J Cardiol. 2001;87:532–536
  134. Polanczyk CA, Rohde LE, Goldman L, et al. Right heart catheterization and cardiac complications in patients undergoing noncardiac surgery: an observational study. JAMA. 2001;286:309–314
  135. Rathore SS, Gersh BJ, Weinfurt KP, Oetgen WJ, Schulman KA, Solomon AJ. The role of reperfusion therapy in paced patients with acute myocardial infarction. Am Heart J. 2001;142:516–519
  136. Sernyak MJ, Desai R, Stolar M, Rosenheck R. Impact of clozapine on completed suicide. Am J Psychiatry. 2001;158:931–937
  137. Sernyak MJ, Rosenheck R, Desai R, Stolar M, Ripper G. Impact of clozapine prescription on inpatient resource utilization. J Nerv Ment Dis. 2001;189:766–773
  138. Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001;285:430–436
  139. Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol. 2001;38:409–414
  140. Welch RD, Zalenski RJ, Frederick PD, et al. Prognostic value of a normal or nonspecific initial electrocardiogram in acute myocardial infarction. JAMA. 2001;286:1977–1984
  141. Wiles NJ, Lunt M, Barrett EM, et al. Reduced disability at five years with early treatment of inflammatory polyarthritis: results from a large observational cohort, using propensity models to adjust for disease severity. Arthritis Rheum. 2001;44:1033–1042
  142. Hagan H, Thiede H. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. J Urban Health. 2000;77:369–382
  143. Holman WL, Li Q, Kiefe CI, et al. Prophylactic value of preincision intra-aortic balloon pump: analysis of a statewide experience. J Thorac Cardiovasc Surg. 2000;120:1112–1119
  144. Murdoch SD, Cohen AT, Bellamy MC. Pulmonary artery catheterization and mortality in critically ill patients. Br J Anaesth. 2000;85:611–615
  145. Potosky AL, Legler J, Albertsen PC, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2000;92:1582–1592
  146. Weiss JP, Gruver C, Kaul S, Harrell FE, Sklenar J, Dent JM. Ordering an echocardiogram for evaluation of left ventricular function: level of expertise necessary for efficient use. J Am Soc Echocardiogr. 2000;13:124–130
  147. Yau TM, El-Ghoneimi YA, Armstrong S, Ivanov J, David TE. Mitral valve repair and replacement for rheumatic disease. J Thorac Cardiovasc Surg. 2000;119:53–60
  148. Lytle BW, Blackstone EH, Loop FD, et al. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg. 1999;117:855–872
  149. Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C. Multicenter Myocardial Ischemia Research Group. Long-term nitrate use may be deleterious in ischemic heart disease: A study using the databases from two large-scale postinfarction studies. Am Heart J. 1999;138:577–585
  150. Schofer J, Rau T, Schluter M, Mathey DG. Restenosis after stenting of matched occluded and non-occluded coronary arteries: should there be a difference?. Eur Heart J. 1999;20:1175–1181
  151. Shepardson LB, Youngner SJ, Speroff T, Rosenthal GE. Increased risk of death in patients with do-not-resuscitate orders. Med Care. 1999;37:727–737
  152. Takizawa T, Haga M, Yagi N, et al. Pulmonary function after segmentectomy for small peripheral carcinoma of the lung. J Thorac Cardiovasc Surg. 1999;118:536–541
  153. Barker FG, Chang SM, Gutin PH, et al. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery. 1998;42:709–720
  154. Barosi G, Ambrosetti A, Centra A, et al. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia. Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Blood. 1998;91:3630–3636
  155. Intrator O, Berg K. Benefits of home health care after inpatient rehabilitation for hip fracture: health service use by Medicare beneficiaries, 1987–1992. Arch Phys Med Rehabil. 1998;79:1195–1199
  156. Regueiro CR, Hamel MB, Davis RB, Desbiens N, Connors AF, Phillips RS, et al. A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival. Am J Med. 1998;105:366–372
  157. Smith NL, Reiber GE, Psaty BM, et al. Health outcomes associated with beta-blocker and diltiazem treatment of unstable angina. J Am Coll Cardiol. 1998;32:1305–1311
  158. Connors AF, Speroff T, Dawson NV, et al. SUPPORT Investigators. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA. 1996;276:889–897
  159. Lieberman E, Lang JM, Cohen A, D'Agostino R, Datta S, Frigoletto FD. Association of epidural analgesia with cesarean delivery in nulliparas. Obstet Gynecol. 1996;88:993–1000
  160. Stone RA, Obrosky DS, Singer DE, Kapoor WN, Fine MJ. Pneumonia Patient Outcomes Research Team (PORT) Investigators. Propensity score adjustment for pretreatment differences between hospitalized and ambulatory patients with community-acquired pneumonia. Med Care. 1995;33S:AS56–AS66
  161. Myers WO, Gersh BJ, Fisher LD, et al. Medical versus early surgical therapy in patients with triple-vessel disease and mild angina pectoris: a CASS registry study of survival. Ann Thorac Surg. 1987;44:471–486
  162. Myers WO, Gersh BJ, Fisher LD, et al. Coronary Artery Surgery Study. Time to first new myocardial infarction in patients with mild angina and three-vessel disease comparing medicine and early surgery: a CASS registry study of survival. Ann Thorac Surg. 1987;43:599–612
  163. Gillinov AM, Blackstone EH, Cosgrove DM, et al. Mitral valve repair with aortic valve replacement is superior to double valve replacement. J Thorac Cardiovasc Surg. 2003;125:1372–1387
  164. Gregg EW, Cauley JA, Stone K, et al. Relationship of changes in physical activity and mortality among older women. JAMA. 2003;289:2379–2386
  165. Horwitz PA, Berlin JA, Sauer WH, Laskey WK, Krone RJ, Kimmel SE. Bleeding risk of platelet glycoprotein IIb/IIIa receptor antagonists in broad-based practice (results from the Society for Cardiac Angiography and Interventions Registry). Am J Cardiol. 2003;91:803–806
  166. Johnson D, Jin Y, Quan H, Cujec B. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada. J Am Coll Cardiol. 2003;42:1438–1445
  167. MacDonald TM, Morant SV, Goldstein JL, Burke TA, Pettitt D. Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs. Gut. 2003;52:1265–1270
  168. Martelli G, Miceli R, De Palo G, et al. Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla?. Cancer. 2003;97:1156–1163
  169. McGuire DK, Anstrom KJ, Peterson ED. Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database. Circulation. 2003;107:1864–1870
  170. Murray PK, Singer M, Dawson NV, Thomas CL, Cebul RD. Outcomes of rehabilitation services for nursing home residents. Arch Phys Med Rehabil. 2003;84:1129–1136
  171. O'Neill BP, Iturria NJ, Link MJ, Pollock BE, Ballman KV, O'Fallon JR. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys. 2003;55:1169–1176
  172. Reddan DN, Szczech LA, Tuttle RH, et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol. 2003;14:2373–2380
  173. Stenestrand U, Wallentin L. Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort. Arch Intern Med. 2003;163:965–971
  174. Urbach DR, Bell CM, Swanstrom LL, Hansen PD. Cohort study of surgical bypass to the gallbladder or bile duct for the palliation of jaundice due to pancreatic cancer. Ann Surg. 2003;237:86–93
  175. Yu DT, Platt R, Lanken PN, et al. Relationship of pulmonary artery catheter use to mortality and resource utilization in patients with severe sepsis. Crit Care Med. 2003;31:2734–2741
  176. Ferraris VA, Ferraris SP, Joseph O, Wehner P, Mentzer RM. Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg. 2002;235:820–827
  177. Goldstein CL, Racz M, Hannan EL. Impact of cardiac catheterization-percutaneous coronary intervention timing on in-hospital mortality. Am Heart J. 2002;144:561–567
  178. Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 2002;287:1815–1821
  179. Jasmer RM, Saukkonen JJ, Blumberg HM, et al. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial. Ann Intern Med. 2002;137:640–647
  180. Kimmel SE, Berlin JA, Kinman JL, et al. Parenteral ketorolac and risk of myocardial infarction. Pharmacoepidemiol Drug Saf. 2002;11:113–119
  181. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Tea consumption and mortality after acute myocardial infarction. Circulation. 2002;105:2476–2481
  182. Patel NC, Grayson AD, Jackson M, et al. The effect off-pump coronary artery bypass surgery on in-hospital mortality and morbidity. Eur J Cardiothorac Surg. 2002;22:255–260
  183. Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB. Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med. 2002;346:822–829
  184. Schomig A, Mehilli J, Holle H, et al. Statin treatment following coronary artery stenting and one-year survival. J Am Coll Cardiol. 2002;40:854–861
  185. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Christiansen CL, Gurwitz JH. Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: cause for concern in the old-old. Arch Intern Med. 2002;162:561–568
  186. Tanasescu M, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Exercise type and intensity in relation to coronary heart disease in men. JAMA. 2002;288:1994–2000
  187. Turner BJ, Laine C, Cohen A, Hauck WW. Effect of medical, drug abuse, and mental health care on receipt of dental care by drug users. J Subst Abuse Treat. 2002;23:239–246
  188. Wright RS, Williams BA, Cramner H, et al. Elevations of cardiac troponin I are associated with increased short-term mortality in noncardiac critically ill emergency department patients. Am J Cardiol. 2002;90:634–636
  189. Ascione R, Nason G, Al-Ruzzeh S, Ko C, Ciulli F, Angelini GD. Coronary revascularization with or without cardiopulmonary bypass in patients with preoperative nondialysis-dependent renal insufficiency. Ann Thorac Surg. 2001;72:2020–2025
  190. Cen YY, Glower DD, Landolfo K, et al. Comparison of survival after mitral valve replacement with biologic and mechanical valves in 1139 patients. J Thorac Cardiovasc Surg. 2001;122:569–577
  191. Kachele H, Kordy H, Richard M. Research group TR-EAT. Therapy amount and outcome of inpatient psychodynamic treatment of eating disorders in Germany: Data from a multicenter study. Psychotherapy Res. 2001;11:239–257
  192. Mehta RH, Bruckman D, Das S, et al. Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg. 2001;122:919–928
  193. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation. 2001;104:2205–2209
  194. O'Day SJ, Boasberg PD, Kristedja TS, et al. High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma. Cancer. 2001;92:609–619
  195. Popiela T, Kulig J, Hanisch J, Bock PR. Influence of a complementary treatment with oral enzymes on patients with colorectal cancers–an epidemiological retrolective cohort study. Cancer Chemother Pharmacol. 2001;47S:S55–S63
  196. Rumsfeld JS, Magid DJ, Plomondon ME, et al. Predictors of quality of life following acute coronary syndromes. Am J Cardiol. 2001;88:781–784
  197. Schnuelle P, Berger S, de Boer J, Persijn G, van der Woude FJ. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation. 2001;72:455–463
  198. Shlipak MG, Browner WS, Noguchi H, Massie B, Frances CD, McClellan M. Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction. Am J Med. 2001;110:425–433
  199. Tu JV, Austin PC, Chan BT. Relationship between annual volume of patients treated by admitting physician and mortality after acute myocardial infarction. JAMA. 2001;285:3116–3122
  200. Auerbach AD, Hamel MB, Davis RB, et al. SUPPORT Investigators; Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Resource use and survival of patients hospitalized with congestive heart failure: differences in care by specialty of the attending physician. Ann Intern Med. 2000;132:191–200
  201. Hannan EL, Racz MJ, Arani DT, McCallister BD, Walford G, Ryan TJ. A comparison of short- and long-term outcomes for balloon angioplasty and coronary stent placement. J Am Coll Cardiol. 2000;36:395–403
  202. Petersen LA, Normand SL, Daley J, McNeil BJ. Outcome of myocardial infarction in Veterans Health Administration patients as compared with Medicare patients. N Engl J Med. 2000;343:1934–1941
  203. Shwartz M, Saitz R, Mulvey K, Brannigan P. The value of acupuncture detoxification programs in a substance abuse treatment system. J Subst Abuse Treat. 1999;17:305–312
  204. Cooper GS, Chak A, Connors AF, Harper DL, Rosenthal GE. The effectiveness of early endoscopy for upper gastrointestinal hemorrhage: a community-based analysis. Med Care. 1998;36:462–474
  205. Fraenkel L, Zhang Y, Chaisson CE, Evans SR, Wilson PW, Felson DT. The association of estrogen replacement therapy and the Raynaud phenomenon in postmenopausal women. Ann Intern Med. 1998;129:208–211
  206. Van den Eeden SK, Glasser M, Mathias SD, Colwell HH, Pasta DJ, Kunz K. Quality of life, health care utilization, and costs among women undergoing hysterectomy in a managed-care setting. Am J Obstet Gynecol. 1998;178:91–100
  207. King SB, Barnhart HX, Kosinski AS, et al. Emory Angioplasty versus Surgery Trial Investigators. Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Am J Cardiol. 1997;79:1453–1459
  208. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:115–121
  209. Fiebach NH, Cook EF, Lee TH, et al. Outcomes in patients with myocardial infarction who are initially admitted to stepdown units: data from the Multicenter Chest Pain Study. Am J Med. 1990;89:15–20
  210. Cepeda MS, Boston R, Farrar JT, Strom BL. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol. 2003;158:280–287
  211. Weitzen S, Lapane KL, Toledano AY, Hume AL, Mor V. Principles for modeling propensity scores in medical research: a systematic literature review. Pharmacoepidemiol Drug Saf. 2004;13:841–853
  212. Greenland S, Robins JM. Confounding and misclassification. Am J Epidemiol. 1985;122:495–506
  213. Robins JM, Greenland S. The role of model selection in causal inference from nonexperimental data. Am J Epidemiol. 1986;123:392–402
  214. Cook EF, Goldman L. Performance of tests of significance based on stratification by a multivariate confounder score or by a propensity score. J Clin Epidemiol. 1989;42:317–324
  215. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387
  216. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373–1379
  217. Braitman LE, Rosenbaum PR. Rare outcomes, common treatments: analytic strategies using propensity scores. Ann Intern Med. 2002;137:693–695
  218. Cepeda MS. The use of propensity scores in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 2000;9:103–104
  219. Drake C. Effects of misspecification of the propensity score on estimators of treatment effect. Biometrics. 1993;49:1231–1236
  220. Dehejia R, Wahba S. Causal effect in non-experimental studies: reevaluating the evaluation of training programs. J Am Stat Assoc. 1999;94:1053–1062
  221. Stürmer T, Schneeweiss S, Brookhart MA, Rothman KJ, Avorn J, Glynn RJ. Analytic Strategies to adjust confounding using Exposure Propensity Scores and Disease Risk Scores: Nonsteroidal Antiinflammatory Drugs and Short-Term Mortality in the Elderly. Am J Epidemiol. 2005;161:891–898
  222. Hosmer DW, Lemenshow S. Applied logistic regression. 2nd ed.. New York: Wiley; 2000;
  223. Perkins SM, Tu W, Underhill MG, Zhou XH, Murray MD. The use of propensity scores in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 2000;9:93–101

PII: S0895-4356(05)00224-6

doi: 10.1016/j.jclinepi.2005.07.004

Journal of Clinical Epidemiology
Volume 59, Issue 5 , Pages 437.e1-437.e24 , May 2006

Article Tools

* Image Usage & Resolution